Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.
- Presentation
Lasers to Treat and Prevent Skin Cancer
Description
The discussion highlights the growing interest and application of laser technology in dermatology, particularly for treating and preventing skin cancer. Using lasers, dermatologists can target and improve skin health, thereby reducing the risk of non-melanoma skin cancers, a prevalent issue in the U.S. The presentation first describes various laser treatments that have shown promising results in clearing basal cell carcinomas, achieving high clearance rates with minimal scarring. It emphasizes advancements in pulsed dye laser and ND: YAG laser treatments that have effectively targeted cancerous cells without significant adverse events. Additionally, the presentation discusses innovative methods such as the use of gold nanoparticles, which show potential for enhancing laser treatment efficacy. It further elaborates on clinical studies proving that both ablative and non-ablative laser procedures significantly lower the incidence of actinic keratoses and skin cancers. Results from randomized controlled studies indicated that these laser treatments lead to a four-fold reduction in actinic keratoses and substantial decreases in skin cancer development. Lastly, the ability of these treatments to rejuvenate skin and enhance its response to UV damage is underscored, reinforcing the concept that lasers not only treat existing skin conditions but also play a preventive role in skin cancer management.
View moreConclusions
- Lasers can improve skin health and reduce skin cancer risk beyond cosmetic applications.
- Lasers, particularly pulsed dye lasers, show high clearance rates for basal cell carcinoma (BCC) without scarring.
- Ablative and non-ablative lasers may increase UVB responses and reduce non-melanoma skin cancer incidences.
- Laser treatments like non-ablative fractional lasers can significantly reduce the risk of subsequent keratinocyte carcinoma in patients with prior skin cancer.
- Further studies support the use of gold nanoparticles and laser therapies for targeting skin cancers more effectively.
- N Konnikov, MM Avram, A Jarell, ZS Tannous. Pulsed dye laser as a novel non-surgical treatment for basal cell carcinomas: Response and follow-up 12-21 months after treatment. Lasers Surg Med 2011; 43 (2): 72-78
- AE Ortiz, RR Anderson, MM Avram. 1064 nm long-pulsed Nd:YAG laser treatment of basal cell carcinoma. 2015; 47(2): 106-110.
- J Ahluwalia, MM Avram, AE Oritz. Outcomes of long-pulsed 1064 nm Nd: YAG laser treatment of basal cell carcinoma: A retrospective review. Lasers Surg Med 2019; 51(1) 34-39
- Pandolfi S, Stecca B. Hedgehog-Gli signaling in basal cell carcinoma and other skin cancers: prospects for therapy. Research and Reports in Biology. 8 May 2015 Volume 2015:6 Pages 55-71.
- Benson TA, Hibler BP, Kotliar D, Avram M. Nonablative Fractional Laser Treatment Is Associated With a Decreased Risk of Subsequent Facial Keratinocyte Carcinoma Development. Dermatol Surg. 2023 Feb 1; 49(2):149-154.
- Arch Dermatol. 2006;142(8):976-982.
- Derm Surg 25 Feb 2013, 39(7):967-973
- J Invest Dermatol. 2012 Jun; 132(6):1591-6.
- J Clin Invest. 2021 Oct 1; 131(19): e150972.